 Rebecca Keith
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Experimental | 2 | 2013 | 133 | 0.770 |
Why?
| | Arthritis, Rheumatoid | 3 | 2017 | 989 | 0.560 |
Why?
| | Pulmonary Fibrosis | 3 | 2011 | 303 | 0.500 |
Why?
| | Lung Diseases, Interstitial | 2 | 2017 | 464 | 0.390 |
Why?
| | Bleomycin | 4 | 2018 | 228 | 0.360 |
Why?
| | Testosterone | 1 | 2013 | 351 | 0.350 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2019 | 83 | 0.330 |
Why?
| | Acute Lung Injury | 1 | 2011 | 310 | 0.320 |
Why?
| | Autoimmunity | 1 | 2013 | 831 | 0.300 |
Why?
| | Idiopathic Pulmonary Fibrosis | 3 | 2018 | 451 | 0.290 |
Why?
| | Lung Diseases | 1 | 2013 | 718 | 0.280 |
Why?
| | Disease Models, Animal | 2 | 2014 | 3730 | 0.220 |
Why?
| | Lung | 5 | 2014 | 3664 | 0.220 |
Why?
| | Lactic Acid | 1 | 2022 | 282 | 0.180 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 7 | 0.170 |
Why?
| | Fatty Acids | 1 | 2022 | 407 | 0.170 |
Why?
| | fas Receptor | 3 | 2018 | 98 | 0.170 |
Why?
| | Lung Compliance | 3 | 2014 | 49 | 0.160 |
Why?
| | Myofibroblasts | 1 | 2018 | 120 | 0.150 |
Why?
| | Cause of Death | 1 | 2019 | 380 | 0.150 |
Why?
| | Mortality | 1 | 2019 | 299 | 0.150 |
Why?
| | Apoptosis | 2 | 2018 | 2484 | 0.140 |
Why?
| | Mice | 7 | 2018 | 15520 | 0.120 |
Why?
| | Collagen | 2 | 2011 | 433 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2011 | 613 | 0.110 |
Why?
| | Mucin-5B | 1 | 2013 | 175 | 0.100 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 254 | 0.100 |
Why?
| | Mice, Mutant Strains | 1 | 2011 | 280 | 0.100 |
Why?
| | Exercise | 1 | 2022 | 1657 | 0.100 |
Why?
| | Sex Characteristics | 2 | 2013 | 671 | 0.100 |
Why?
| | Macrophages, Alveolar | 1 | 2014 | 359 | 0.100 |
Why?
| | Smoke | 1 | 2011 | 143 | 0.090 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1206 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1171 | 0.080 |
Why?
| | Lung Injury | 1 | 2011 | 210 | 0.080 |
Why?
| | Animals | 7 | 2018 | 33381 | 0.080 |
Why?
| | Up-Regulation | 1 | 2011 | 872 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2436 | 0.070 |
Why?
| | Fibroblasts | 1 | 2011 | 842 | 0.070 |
Why?
| | Male | 9 | 2022 | 57801 | 0.070 |
Why?
| | Female | 8 | 2022 | 61565 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2018 | 2680 | 0.060 |
Why?
| | Survival Analysis | 2 | 2017 | 1267 | 0.050 |
Why?
| | Fever | 1 | 2022 | 283 | 0.050 |
Why?
| | Occupations | 1 | 2019 | 37 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2014 | 4908 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2022 | 586 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2022 | 940 | 0.040 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 67 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2014 | 2025 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2022 | 477 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 67 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2018 | 190 | 0.040 |
Why?
| | Forecasting | 1 | 2019 | 353 | 0.040 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2017 | 58 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2022 | 648 | 0.040 |
Why?
| | Reference Values | 1 | 2018 | 774 | 0.040 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2017 | 41 | 0.040 |
Why?
| | Vital Capacity | 1 | 2017 | 260 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 564 | 0.030 |
Why?
| | Rheumatoid Factor | 1 | 2017 | 156 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 627 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1636 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 12978 | 0.030 |
Why?
| | Middle Aged | 3 | 2022 | 27617 | 0.030 |
Why?
| | Humans | 7 | 2022 | 118974 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4077 | 0.030 |
Why?
| | Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 7 | 0.030 |
Why?
| | Hydroxyproline | 1 | 2014 | 24 | 0.030 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2014 | 17 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1691 | 0.030 |
Why?
| | Mucin 5AC | 1 | 2013 | 46 | 0.030 |
Why?
| | Remission Induction | 1 | 2014 | 247 | 0.030 |
Why?
| | Ear, Middle | 1 | 2013 | 92 | 0.030 |
Why?
| | United States | 2 | 2019 | 12555 | 0.030 |
Why?
| | Cilia | 1 | 2013 | 160 | 0.030 |
Why?
| | Phagocytosis | 1 | 2013 | 364 | 0.030 |
Why?
| | Bacterial Infections | 1 | 2013 | 227 | 0.030 |
Why?
| | Chemokine CXCL1 | 1 | 2011 | 69 | 0.030 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 60 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 136 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3171 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2011 | 127 | 0.020 |
Why?
| | Adult | 2 | 2022 | 31512 | 0.020 |
Why?
| | Recovery of Function | 1 | 2014 | 604 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 394 | 0.020 |
Why?
| | Smoking | 1 | 2017 | 1487 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 827 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3443 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2011 | 462 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1720 | 0.020 |
Why?
| | Macrophages | 1 | 2013 | 1324 | 0.020 |
Why?
| | Models, Biological | 1 | 2013 | 1715 | 0.020 |
Why?
| | Sex Factors | 1 | 2011 | 1781 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2707 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1137 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1597 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2513 | 0.020 |
Why?
| | Age Factors | 1 | 2011 | 2995 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 6412 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2566 | 0.010 |
Why?
| | Asthma | 1 | 2013 | 2158 | 0.010 |
Why?
| | Prospective Studies | 1 | 2011 | 6471 | 0.010 |
Why?
| | Aged | 1 | 2017 | 19657 | 0.010 |
Why?
|
|
Keith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|